Pulse Biosciences Inc (FRA:6L8)
€ 19.1 -0.2 (-1.04%) Market Cap: 1.25 Bil Enterprise Value: 1.18 Bil PE Ratio: 0 PB Ratio: 16.64 GF Score: 40/100

Q1 2020 Pulse Biosciences Inc Earnings Call Transcript

May 11, 2020 / 08:30PM GMT
Release Date Price: €10.1 (+17.05%)
Operator

Greetings, and welcome to the Pulse Biosciences First Quarter 2020 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Philip Taylor, Investor Relations for Pulse Biosciences. Thank you. You may begin.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. I hope that you all are keeping well during this time. We are hosting our call from a number of different locations today, so please bear with us if there are any technical challenges or pauses.

Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, May 11, 2020, only and will include forward-looking statements and opinion statements. These include statements regarding our plans and expectations relating to regulatory clearance, including the process, time lines and expected outcomes; our commercial, operational, scientific, clinical and financial projection; products, including the uses

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot